Airworthiness Directives: Bombardier BD-700 Airplanes

The Federal Aviation Administration (FAA) has issued a proposed Airworthiness Directive (AD) concerning Bombardier BD-700 series airplanes. This proposed rule addresses a potential safety issue with baggage door bolts and is open for public comment.

Sanchez v. Acedo - Court Opinion

The California Courts of Appeal, 4th Appellate District, Division 1, have issued an opinion in the case of Sanchez v. Acedo, case number D086356. The opinion is available for review in PDF and DOCX formats.

CPSC Request for Comment on Gate and Enclosure Safety Standard Revision

The Consumer Product Safety Commission (CPSC) is requesting public comment on a proposed revision to the voluntary standard for gates and enclosures. This action is part of an ongoing effort to update safety requirements for these products. The comment period closes on February 10, 2026.

CPSC Proposed Rule Revision for Infant and Cradle Swings

The Consumer Product Safety Commission (CPSC) has issued a proposed rule revision concerning the voluntary standard for infant and cradle swings. The agency is requesting public comments on the proposed changes.

CPSC Proposes Revision to Voluntary Standard for Portable Hook-On Chairs

The Consumer Product Safety Commission (CPSC) has issued a proposed rule to revise the voluntary standard for portable hook-on chairs. The agency is seeking public comment on the proposed changes to 16 CFR 1233.

CPSC Proposes Crib Mattress Safety Standard

The Consumer Product Safety Commission (CPSC) has proposed a new safety standard for crib mattresses. This proposed rule is open for public comment until March 16, 2026. Manufacturers and retailers of crib mattresses will be affected by this new standard.

CPSC Proposed Revision to Voluntary Standard for Baby Cribs

The Consumer Product Safety Commission (CPSC) has issued a proposed rule to revise the voluntary standard for full-size baby cribs. The agency is requesting public comments on this proposed revision.

Executive Order 14386: Strengthening National Defense with Coal Power

President Trump issued Executive Order 14386, aiming to strengthen national defense by leveraging America's clean coal power generation fleet. The order, signed on February 11, 2026, directs federal agencies to consider the role of coal power in national security strategies.

Executive Order 14385: Protecting National Security and Welfare

President Trump signed Executive Order 14385, aimed at protecting the national security and welfare of the United States and its citizens from criminal actors and other public safety threats. The order was signed on February 6, 2026, and published in the Federal Register on February 11, 2026.

Executive Order Ending Certain Tariff Actions

President Trump signed Executive Order 14389, published on February 25, 2026, which terminates certain tariff actions against seven countries. This action revokes previous trade restrictions and is effective immediately upon publication.

Executive Order 14387: Ensuring Supply of Elemental Phosphorus and Glyphosate

President Trump issued Executive Order 14387 to ensure an adequate domestic supply of elemental phosphorus and glyphosate-based herbicides, critical for national defense. The order invokes authorities under the Defense Production Act to address potential supply chain vulnerabilities for these key materials.

Executive Order Suspending Duty-Free De Minimis Treatment

The Executive Office of the President has issued Executive Order 14388, continuing the suspension of duty-free de minimis treatment for all countries. This action impacts importers and exporters by potentially altering the customs treatment of goods.

Presidential Proclamation on Temporary Increase in Lean Beef Imports

The President has issued a proclamation temporarily increasing the quota for lean beef imports into the United States. This measure aims to ensure affordable beef for American consumers. The proclamation was published in the Federal Register on February 13, 2026.

President George Washington's Birthday, 2026 Proclamation

The Executive Office of the President has issued a proclamation designating President George Washington's Birthday for 2026. This document officially marks the observance of the holiday.

Presidential Proclamation: Temporary Import Surcharge for Payments Problems

The President has issued a proclamation imposing a temporary import surcharge to address international payments problems. This action, published in the Federal Register on February 25, 2026, introduces new import duties aimed at resolving fundamental international financial issues.

National Angel Family Day 2026 Proclamation

The Executive Office of the President has issued a proclamation designating February 26, 2026, as National Angel Family Day. This document officially recognizes the observance of this day.

Trividia Health Corrects True Metrix Blood Glucose Meters Due to Injuries and Death

The FDA issued an Early Alert regarding Trividia Health's correction of TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO, and TRUE METRIX PRO Blood Glucose Monitoring Systems due to reports of injuries and death. The correction updates instructions for the E-5 error code, which indicates very high blood glucose results or test strip errors.

Olympus Insufflation Units Recalled by FDA Due to Software Issues

The FDA has classified a recall of Olympus High Flow Insufflation Units (models UHI, UHI-2, UHI-3) as Class I due to a software issue that could lead to overpressure events, potentially causing serious injury or death. Olympus is removing these discontinued devices from the market, and users are instructed to immediately cease usage and quarantine affected units.

FDA Early Alert: Abiomed Heart Pump Purge Cassette Issue

The FDA issued an Early Alert regarding a potentially high-risk issue with Abiomed's Impella Purge Cassettes and Pump Sets. The issue involves an increased risk of purge leaks in Generation 1 Purge Cassettes, which could lead to pump stops and patient death. Abiomed has recalled affected products, and four serious injuries have been reported.

Boston Scientific Recalls AXIOS Stents Due to Deployment Issues

The FDA is alerting the public about a recall of Boston Scientific AXIOS Stents and Electrocautery Enhanced Delivery Systems due to issues with stent deployment. The recall has been identified as the most serious type, with 167 injuries and 3 deaths reported. Healthcare providers are instructed to immediately stop distribution or use of affected devices.

Go Raw LLC Recalls Cat Food Due to Low Thiamine

Go Raw LLC is voluntarily recalling one lot of Quest Cat Food Chicken Recipe Freeze Dried Nuggets due to low thiamine levels. The recall was initiated after one report of illness in a cat, which has since recovered. Consumers are advised to stop feeding the product and return it for a refund.

Made Fresh Salads Recalls Cream Cheese for Listeria Contamination

Made Fresh Salads, Inc. is recalling assorted flavors of cream cheese due to potential contamination with Listeria monocytogenes. The recall was initiated after the company's own sampling revealed contamination from a mixer. No illnesses have been reported to date.

Saputo USA Recalls Great Value Cottage Cheese Due to Health Risk

Saputo USA is recalling Great Value cottage cheese sold at Walmart due to potential under-pasteurization, posing a health risk. The FDA is aware of the recall, which affects products distributed in multiple states. Consumers are advised to return affected products for a refund.

Elite Treats Recalls Chicken Chips for Salmonella Contamination

Elite Treats, LLC. is recalling a single lot of chicken dog treats due to potential Salmonella contamination. The recall impacts products sold to feed stores in Alabama, Florida, Georgia, North Carolina, and South Carolina. No illnesses have been reported to date.

Lockout Supplements Recalls Chocolate Syrup for Undeclared Sildenafil

Lockout Supplements is voluntarily recalling all lots of Boner Bears Chocolate Syrup nationwide due to undeclared sildenafil. The undeclared ingredient poses a risk of dangerous blood pressure reduction when interacting with prescribed medications.

DOJ requires Reddy Ice to divest assets for Arctic Glacier acquisition

The Department of Justice's Antitrust Division requires Reddy Ice and Arctic Glacier to divest assets in five states to proceed with their acquisition. This action aims to preserve competition for packaged ice sold to retail chains, airlines, and airline caterers, preventing potential price increases and service quality decreases.

Executive Pleads Guilty to Bid-Rigging Conspiracy Affecting US Military

The Department of Justice announced that Thomas C. Rollins, president of a metal fabrication company, pleaded guilty to a conspiracy to rig bids for contracts affecting US military installations. The conspiracy generated over $8.5 million in rigged procurements.

DOJ Indicts Owners for Bid Rigging Affecting Mississippi Schools

The DOJ Antitrust Division announced the indictment of three individuals for orchestrating bid rigging schemes affecting the sale of sports equipment to public schools in Mississippi. The defendants allegedly conspired to manipulate bids, impacting at least 44 schools and millions of dollars in taxpayer funds.

DOJ Sues OhioHealth for Anticompetitive Healthcare Contracts

The Department of Justice's Antitrust Division, along with the Attorney General of Ohio, has filed a civil antitrust lawsuit against OhioHealth Corporation. The suit challenges anticompetitive contract restrictions that allegedly increase healthcare costs for Ohio patients by limiting insurer options and preventing competition.

DOJ and FTC Seek Comment on Business Collaboration Guidance

The Department of Justice and the Federal Trade Commission are seeking public comment on potential new guidance for collaborations among competitors. This initiative aims to replace previous guidelines withdrawn in December 2024 and provide clarity on antitrust issues related to business collaborations, joint ventures, and alliances.

SEC v. Tai Mo Shan Limited - Cease-and-Desist Order and $123M Penalty

The SEC has extended the deadline for the Division of Enforcement to submit a Proposed Plan of Distribution for the Fair Fund established in the cease-and-desist order against Tai Mo Shan Limited. The order requires Tai Mo Shan to pay a total of $123,095,287.00 in disgorgement, interest, and penalties for unregistered securities offerings.

SEC Reinstates Accountant Joseph Jennings, CPA After Suspension

The SEC has issued an order reinstating Joseph Jennings, CPA, to practice before the Commission as an accountant. Jennings was suspended in 2018 for insider trading violations related to the H.J. Heinz Company and Kraft Foods Group, Inc. merger.

SEC v. Madison Capital Funding LLC - Investment Adviser Sanctions

The SEC instituted administrative and cease-and-desist proceedings against Madison Capital Funding LLC, an investment adviser. The firm allegedly failed to determine fair market value for trades with pooled investment vehicles it advised during a period of market disruption.

SEC Bars Ejiro Ode Okuma for Fraud and Misappropriation

The SEC has barred Ejiro Ode Okuma from associating with any regulated entity following findings of fraud and misappropriation of over $9 million from a client. A final judgment was entered against Okuma, permanently enjoining him from future violations of securities laws.

FCA and Independent Football Regulator Sign Memorandum of Understanding

The Financial Conduct Authority (FCA) and the Independent Football Regulator (IFR) have signed a Memorandum of Understanding (MoU). This agreement outlines how the two organizations will collaborate to ensure effective regulation where football and financial services intersect.

FCA Launches New Regulatory Priorities Reports

The FCA has launched new Regulatory Priorities reports, starting with the insurance sector, to replace over 40 previous portfolio letters. These new reports aim to streamline communication and provide clearer, higher-level guidance for regulated firms.

FCA Proposes Action to Close Credit File Gaps for Borrowers

The FCA is consulting on proposals to require lenders to share credit information with all designated consumer credit reference agencies (CRAs). This aims to close gaps in consumers' credit files and ensure they more accurately reflect financial circumstances. The consultation closes on May 1, 2026.

CMA Advocates Non-Compete Clause Reform and Salary Threshold Ban

The UK's Competition and Markets Authority (CMA) has responded to a government working paper on reforming non-compete clauses in employment contracts. The CMA advocates for reforms, including a ban on non-competes below a salary threshold, to enhance labour market mobility.

FCA Stablecoin Regulatory Sandbox Testing

The FCA has selected four firms to participate in its regulatory sandbox to test stablecoin innovation. This initiative aims to gather real-world data to inform the development of future UK stablecoin regulations, with findings expected to shape final rules later in 2026.

Payments Forward Plan Published by Committee

The Payments Vision Delivery Committee, comprising HM Treasury, Bank of England, FCA, and PSR, has published the Payments Forward Plan. This plan outlines upcoming initiatives in retail and wholesale payments, including digital assets, to foster innovation and economic growth.

CMA Investigates ABF Acquisition of Hovis Merger

The UK's Competition and Markets Authority (CMA) has launched an investigation into the anticipated acquisition of Hovis Group Limited by Associated British Foods plc. The inquiry is currently in Phase 2, with a statutory deadline of June 24, 2026.

CMA Investigates Hays Travel Merger

The UK's Competition and Markets Authority (CMA) has launched merger inquiries into Hays Travel's acquisitions of Polka Dot Travel and Millington Travel. Initial enforcement orders have been served, and phase 1 decision deadlines are set for April 2026.

Homes England Subsidy Referral for 2020 Developments Luton

The UK's Competition and Markets Authority (CMA) has published its final report advising Homes England on a proposed £29.5 million subsidy to 2020 Developments (Luton) Limited. This subsidy is for infrastructure development to unlock residential and employment space.

CMA Merger Inquiry: LDC acquires Green Label

The CMA has opened a merger inquiry into the acquisition of Green Label Holdings Limited by Société LDC SA. An initial enforcement order has been served, and an invitation to comment is open until March 9, 2026, to gather views on potential competition impacts.

Post Office Subsidy Scheme Report and Consultation

The CMA's Subsidy Advice Unit has accepted a request for a report on the proposed £609.2m Post Office Transformation Subsidy Scheme. The Department for Business and Trade is seeking advice on compliance with subsidy control requirements. Comments are due by March 11, 2026.

EMA Recommends Six New Medicines for Approval

The European Medicines Agency's CHMP has recommended six new medicines for marketing authorisation and nine for extension of therapeutic indications. These recommendations cover treatments for various conditions including menopausal symptoms, liver disease, a rare genetic disorder, influenza, and graft-versus-host disease.

EMA Recommends Kygevvi for Rare TK2d Disease Treatment

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Kygevvi, a new treatment for the rare genetic disease thymidine kinase 2 deficiency (TK2d). This recommendation is based on clinical study data showing improvement in motor function for pediatric patients.

EMA Recommends Withdrawal of Levamisole Medicines

The European Medicines Agency (EMA) recommends the withdrawal of marketing authorisations for medicines containing levamisole due to the serious side effect of leukoencephalopathy. This recommendation follows an EU-wide review concluding that the benefits of these medicines no longer outweigh their risks for treating parasitic worm infections.

Levamisole withdrawn from EU market due to leukoencephalopathy risk

The EMA's PRAC has recommended the withdrawal of marketing authorisations for all medicines containing levamisole from the EU market. This decision is due to the confirmed risk of leukoencephalopathy, a serious brain side effect, where the benefits of the medicine no longer outweigh the risks for treating parasitic worm infections.

CVMP Opinions and Guidelines Update

The EMA's Committee for Veterinary Medicinal Products (CVMP) adopted positive opinions for several variations to existing veterinary medicinal products and discussed pharmacovigilance signals. These updates primarily involve product information changes based on signal management processes.